ZA914577B - Gemfibrozil formulations - Google Patents

Gemfibrozil formulations

Info

Publication number
ZA914577B
ZA914577B ZA914577A ZA914577A ZA914577B ZA 914577 B ZA914577 B ZA 914577B ZA 914577 A ZA914577 A ZA 914577A ZA 914577 A ZA914577 A ZA 914577A ZA 914577 B ZA914577 B ZA 914577B
Authority
ZA
South Africa
Prior art keywords
gemfibrozil
formulations
gemfibrozil formulations
Prior art date
Application number
ZA914577A
Other languages
English (en)
Inventor
Isaac Ghebre-Sellassie
Ghebre-Sellassie Isaac
Mahdi B Fawzi
B Fawzi Mahdi
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of ZA914577B publication Critical patent/ZA914577B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA914577A 1990-06-15 1991-06-14 Gemfibrozil formulations ZA914577B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53915890A 1990-06-15 1990-06-15

Publications (1)

Publication Number Publication Date
ZA914577B true ZA914577B (en) 1992-03-25

Family

ID=24150041

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA914577A ZA914577B (en) 1990-06-15 1991-06-14 Gemfibrozil formulations

Country Status (9)

Country Link
US (1) US5281421A (xx)
EP (1) EP0462067A1 (xx)
JP (1) JPH04230216A (xx)
KR (1) KR920000316A (xx)
AU (1) AU641509B2 (xx)
FI (1) FI912884A (xx)
IE (1) IE912041A1 (xx)
PT (1) PT97970A (xx)
ZA (1) ZA914577B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU212428B (en) * 1994-05-13 1996-06-28 Egyt Gyogyszervegyeszeti Gyar Process to prepare pharmaceutical compositions containing gemfibrozyl
EP1499296B1 (en) * 2002-04-15 2012-04-04 MAP Pharmaceuticals Inc Formulation of fine particles using liquefied or dense gases

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4344934A (en) * 1978-11-20 1982-08-17 American Home Products Corporation Therapeutic compositions with enhanced bioavailability
US4620974A (en) * 1983-07-07 1986-11-04 American Home Products Corporation Pharmaceutical composition containing a liquid lubricant
US4753800A (en) * 1985-10-04 1988-06-28 Warner-Lambert Company Medicament adsorbates and their preparation
US4778676A (en) * 1985-12-20 1988-10-18 Warner-Lambert Company Confectionery delivery system for actives
US4716033A (en) * 1986-03-27 1987-12-29 Warner-Lambert Company Medicament adsorbates with surfactant and their preparation
US4816264A (en) * 1986-06-06 1989-03-28 Warner-Lambert Company Sustained release formulations
US4865850A (en) * 1986-09-08 1989-09-12 See/Shell Biotechnology, Inc. Dietary fat reduction
ZA876640B (en) * 1986-09-26 1988-03-08 Warner-Lambert Company Treated lipid regulator
US4814354A (en) * 1986-09-26 1989-03-21 Warner-Lambert Company Lipid regulating agents
WO1988005296A2 (en) * 1987-01-27 1988-07-28 Warner-Lambert Company Lpid regulating compositions
US4859703A (en) * 1987-06-15 1989-08-22 Warner-Lambert Company Lipid regulating compositions
US5023088A (en) * 1987-06-25 1991-06-11 Alza Corporation Multi-unit delivery system
US4929605A (en) * 1987-10-07 1990-05-29 Merrell Dow Pharmaceuticals Inc. Pharmaceutical composition for piperidinoalkanol derivatives
FR2627696B1 (fr) * 1988-02-26 1991-09-13 Fournier Innovation Synergie Nouvelle forme galenique du fenofibrate
US4891220A (en) * 1988-07-14 1990-01-02 Immudyne, Inc. Method and composition for treating hyperlipidemia
US4971804A (en) * 1989-02-02 1990-11-20 Warner-Lambert Company Water dispersible gemfibrozil compositions
US4927639A (en) * 1989-02-02 1990-05-22 Warner-Lambert Company Modified release gemfibrozil composition
US4925676A (en) * 1989-02-02 1990-05-15 Warner-Lambert Company Extended release gemfibrozil composition
US5126348A (en) * 1989-09-26 1992-06-30 The University Of Colorado Foundation, Inc. Bioavailability enhancers
EP0475894A1 (en) * 1990-08-27 1992-03-18 Warner-Lambert Company Gemfibrozil formulations

Also Published As

Publication number Publication date
AU7838091A (en) 1991-12-19
KR920000316A (ko) 1992-01-29
FI912884A (fi) 1991-12-16
FI912884A0 (fi) 1991-06-14
AU641509B2 (en) 1993-09-23
IE912041A1 (en) 1991-12-18
JPH04230216A (ja) 1992-08-19
US5281421A (en) 1994-01-25
EP0462067A1 (en) 1991-12-18
PT97970A (pt) 1992-03-31

Similar Documents

Publication Publication Date Title
GB9118028D0 (en) Improved transdrmal formulations
GB9207832D0 (en) Formulations
GB8908250D0 (en) Formulations
EP0757891A3 (de) Feststoff-Formulierungen
AP9000174A0 (en) Antiparasitical formulations
AP9000236A0 (en) Pharmaceutical formulations
ZA916749B (en) Gemfibrozil formulations
ZA914577B (en) Gemfibrozil formulations
GB8924207D0 (en) Formulations
GB9025175D0 (en) Formulations
GB9021593D0 (en) Formulations
GB9021382D0 (en) Formulations
GB9022208D0 (en) Formulations
ZA916689B (en) Solid formulations
GB9100997D0 (en) Formulations
GB9107640D0 (en) Formulations
GB9107641D0 (en) Formulations
GB9124723D0 (en) Formulations
GB9124661D0 (en) Formulations
GB9120396D0 (en) Formulations
GB9107669D0 (en) Formulations
GB9105373D0 (en) Formulations
GB9105082D0 (en) Formulations
GB9105386D0 (en) Formulations
GB9116398D0 (en) Novel formulations